Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.
about
Stem cells as cellular vehicles for gene therapy against glioblastomaCardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart.Effect of stem cell application on Asherman syndrome, an experimental rat model.Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair.Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways.Identification of telocytes in skeletal muscle interstitium: implication for muscle regenerationSecretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study.Perfusion defect size predicts engraftment but not early retention of intra-myocardially injected cardiosphere-derived cells after acute myocardial infarctionCardiosphere-Derived Cells Facilitate Heart Repair by Modulating M1/M2 Macrophage Polarization and Neutrophil Recruitment.Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.Restored perfusion and reduced inflammation in the infarcted heart after grafting stem cells with a hyaluronan-based scaffold.Adaptive inflammatory microenvironment for cell-based regeneration in ischemic cardiovascular disease.Interferon-gamma induced adipose tissue inflammation is linked to endothelial dysfunction in type 2 diabetic miceAT2 receptors targeting cardiac protection post-myocardial infarction.Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.Live monitoring of small vessels during development and disease using the flt-1 promoter element.Melatonin facilitates adipose-derived mesenchymal stem cells to repair the murine infarcted heart via the SIRT1 signaling pathway.Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy.Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction.Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression.Cardiac primitive cells become committed to a cardiac fate in adult human heart with chronic ischemic disease but fail to acquire mature phenotype: genetic and phenotypic study.Mesenchymal stem cells neither fully acquire the electrophysiological properties of mature cardiomyocytes nor promote ventricular arrhythmias in infarcted rats.S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.Selection of a common multipotent cardiovascular stem cell using the 3.4-kb MesP1 promoter fragmentStem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathyPioglitazone Protects Mesenchymal Stem Cells against -Cresol-Induced Mitochondrial Dysfunction via Up-Regulation of PINK-1
P2860
Q26771835-9C3CB8B9-D6ED-490A-9A14-0D526CE139D3Q30528601-33D68302-1876-48D5-9A2D-BB51146ED143Q34037182-24A39E55-68BD-472C-AA4F-71C25C07ADF9Q34331636-6743C9DE-6127-434D-AEE8-A331F2DA0EACQ34579503-4936DE71-19D3-4F94-8775-B75745E37DB1Q35216081-FF25ABC0-BBC4-472C-B6DB-355FEDB8B74FQ35587397-4FE3E459-6490-4941-ACD1-1BB60A27A71DQ35587462-D22ED427-82BB-43BE-8E06-6F37E221D30CQ36169471-E13635F7-9770-4B38-9F3A-C154366132BAQ36233665-6808E421-657D-49AD-A734-A301C4C55242Q37294128-8E33ABF4-B2F1-4CD9-B289-67378408FEFBQ37496503-C69A106F-F3AD-43D8-B356-59FF0B1E5E6AQ37627191-6914D2BF-6FE6-4626-8A85-F2B358F22057Q38208962-BCCEA18C-ACAC-425D-A97D-717C23450F9DQ38766012-843DFBCC-6FEF-49CB-A1D4-8CEB41F2894DQ39387425-EC79DC62-9CCC-457C-A918-6EDB4601167FQ40274980-325FFBBD-C8F7-422A-8F4E-F89721053832Q42267231-B8566B91-75B0-48F0-9CD3-1C5935AD7DE6Q47579457-FD8E5F1E-CAB9-4279-9018-0BE7458B06D4Q47991605-E44C0968-1F96-46B2-BC2A-371C6642B7ADQ50545634-ECD7633B-1282-4313-9B23-080C37D093B6Q53160097-3B374AE4-0209-4401-9DAA-6C5A47A0397CQ54325092-F7A6230C-13AF-410B-A929-DA13982D7959Q54449632-1B01947B-8CA9-4B46-9B1D-BC6D1E1C97B5Q56854260-9DBA69CD-2F7C-4EFF-900D-E94E753AB41BQ58816057-467C786B-8F06-43D9-A383-A54814FE739DQ59133993-8AA72BB1-B031-413F-BACA-A5177F7BA320
P2860
Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Stem cell-based therapies in i ...... ocirculation and inflammation.
@ast
Stem cell-based therapies in i ...... ocirculation and inflammation.
@en
type
label
Stem cell-based therapies in i ...... ocirculation and inflammation.
@ast
Stem cell-based therapies in i ...... ocirculation and inflammation.
@en
prefLabel
Stem cell-based therapies in i ...... ocirculation and inflammation.
@ast
Stem cell-based therapies in i ...... ocirculation and inflammation.
@en
P2093
P2860
P1476
Stem cell-based therapies in i ...... ocirculation and inflammation.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00395-011-0168-X
P577
2011-03-23T00:00:00Z